Back to Stakeholders

The Clinical Psychedelic Lab, led by Dr. Paul Liknaitzky, conducts robust clinical trials exploring the efficacy and safety of psychedelic-assisted therapies for various mental health conditions within the Australian healthcare context.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Government funding received

1 grant

MRFF — Psilocybin-assisted psychotherapy for treatment-resistant depression

2022–2027

Part of the A$14.8M MRFF clinical-trials package announced January 2022. Monash-led team evaluates the efficacy of psilocybin-assisted psychotherapy in treatment-resistant depression. PIs from the Monash Clinical Psychedelic Lab.

Source

Quick Facts

Type
academic
HQ
Australia
Website
Visit

Collaborated Trials

1